| Financial Year |
March 31 2023 |
| Monetary Funds |
455,454,921.76 |
| Held-for-trading Financial Assets |
58,295,723.76 |
| Notes Receivable |
-- |
| Accounts Receivable |
160,306,820.94 |
| Advances to Suppliers |
52,360,976.43 |
| Other Receivables |
3,886,159.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,965,922.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,060,635.64 |
| Total Current Assets |
904,167,320.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,905,395.80 |
| Long-term Equity Investment |
420,733,244.77 |
| Investment Properties |
-- |
| Fixed Assetes |
235,705,664.06 |
| Under-construction Projects |
269,459,040.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,875,566.10 |
| R&D expenses |
-- |
| Goodwill |
7,411,884.47 |
| Long-Term Deferred and Prepaid Expenses |
8,194,175.20 |
| Deferred Income Tax Assets |
13,481,419.06 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,073,323,240.56 |
| Total Assets |
1,977,490,561.13 |
| Short-Term Loans |
111,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
169,007,837.10 |
| Accounts Payable |
99,975,060.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,461,994.24 |
| Taxes Payable |
7,759,880.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,814,352.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,440,146.45 |
| Other Current Liabilities |
3,748,800.66 |
| Sub-Total of Current Liabilities |
469,037,219.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,939,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
88,740,965.09 |
| Total Liabilities |
557,778,184.85 |
| Paid-In Capital(Or Share Stock) |
244,660,327.00 |
| Capital Surplus |
439,938,715.77 |
| Surplus Reserve |
61,821,294.50 |
| LESS:Treasury Stock |
24,500,546.00 |
| Undistributed Profits |
686,423,580.83 |
| Minority Stockholder's Interest |
21,743,266.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,397,969,109.63 |
| Owner's Equity（Stockholder's Equity） |
1,419,712,376.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,977,490,561.13 |
